KIM AUSTIN D. 4
4 · ACADIA PHARMACEUTICALS INC · Filed May 2, 2023
Insider Transaction Report
Form 4
KIM AUSTIN D.
EVP AND GENERAL COUNSEL
Transactions
- Sale
Common Stock
2023-05-01$21.18/sh−917$19,422→ 25,513 total - Exercise/Conversion
Common Stock
2023-04-29+3,005→ 26,430 total - Exercise/Conversion
Restricted Stock Units
2023-04-29−3,005→ 0 total→ Common Stock (3,005 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
- [F2]The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F3]The restricted stock units vest in four equal annual installments beginning 4/29/2020.